| Animal
pharming is a controversial method which allows the use of genes that
may code for a useful pharmaceutical drug or bioactive chemical to be
incorporated into an animal host that may not normally produce it. As
a consequence, the host animal is then able to produce the required product
in large quantities, which can then be purified and used.
Among the readers
polled, 58% were aware of such a method, while 42% had not heard of the
term. Among the 58 who responded, only 13 would have no qualms in using
drugs of such sources, while 39 maintained their reservation, and a further
2 people gave a definitive no.
52% of readers
believe that this constitutes animal exploitation to a certain extent,
while 37% do not think so, and 3% strongly believed that it was. Hence,
when queried on whether research and commercialisation on this method
should be futher encouraged, 16% had no qualms over throwing their support,
while 2% was strongly opposed. However, readers generally believed that
animal pharming should be regulated.
In conclusion,
out of 62 respondents, 24 believed that the medical world would benefit
from animal pharming, while a further 27 maintained only the possibility.
5 respondents were opposed to this, and probably believed in the development
of other alternative methods in its place.
|